India | Imports and Exports | World | Antibiotics | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 2941 "Antibiotics" from India totalled $ 1 billion in 2023. Sales of commodity group 2941 from India went up by 8.34% compared to 2022: exports of commodity group 2941 "Antibiotics" went up by $ 77 million (cumulative exports of commodity group 2941 from India amounted $928 million in 2022)
Exports of commodity group 2941 "Antibiotics" amounted to 0.233% of total exports from India (cumulative merchandise exports from India totalled $ 431 billion in 2023). The share of commodity group 2941 in total exports from India increased by 0.028 p.p. compared to 2022 (it was 0.205% in 2022 and cumulative exports from India were equal to $ 452 billion).
Exports of commodity group 2941 amounted to 5.16% of total sales of group "" from India in 2023 (the value of exports of commodity group from India amounted to $19.4 billion in 2023). The share of exports of commodity group 2941 in sales of commodity group from India increased by 0.921 p.p. compared to 2022 (it was 4.24% in 2022, and exports of commodity group from India were $21 billion).
Where does India export Antibiotics?
Top export destinations of "Antibiotics" from India in 2023:
- Bangladesh with a share of 8.49% (85 million US$)
- China with a share of 7.92% (79 million US$)
- Vietnam with a share of 6.76% (68 million US$)
- Turkey with a share of 5.76% (57 million US$)
- Italy with a share of 5.6% (56 million US$)
- Brazil with a share of 4.37% (44 million US$)
- Korea with a share of 3.93% (39 million US$)
- Netherlands with a share of 3.32% (33 million US$)
- United Arab Emirates with a share of 3.3% (33 million US$)
- United Kingdom with a share of 2.91% (29 million US$)
Exports structure of 2941 - Antibiotics - from India in 2023 represented by the following main commodity groups:
- 62% (625 million US$): 294190 - Antibiotics & their derivatives (excl. of 2941); salts thereof
- 25% (260 million US$): 294110 - Penicillins & their derivatives with a penicillanic acid structure; salts thereof
- 11.4% (115 million US$): 294150 - Erythromycin & its derivatives; salts thereof
- 0.368% (3.7 million US$): 294140 - Chloramphenicol & its derivatives; salts thereof
- 0.158% (1.59 million US$): 294130 - Tetracyclines & their derivatives; salts thereof
- 0.005% (51 thousand US$): 294120 - Streptomycins & their derivatives; salts thereof
The value of imports of commodity group 2941 "Antibiotics" to India totalled $ 1.96 billion in 2023. Sales of commodity group 2941 to India went up by 23% compared to 2022: imports of commodity group 2941 "Antibiotics" went up by $ 375 million (the value of imports of commodity group 2941 to India was equal to $1.58 billion in 2022)
Imports of commodity group 2941 "Antibiotics" accounted for 0.292% of total import flow to India (in 2023, total imports to India amounted to $ 672 billion). The share of commodity group 2941 in total imports to India increased by 0.075 p.p. compared to 2022 (it was 0.216% in 2022 and cumulative imports to India were equal to $ 732 billion).
Imports of commodity group 2941 reached 7.2% of total imports of group "" to India in 2023 (imports of commodity group to India totalled $27 billion in 2023). The share of purchases of commodity group 2941 in total imports of commodity group to India increased by 1.87 p.p. compared to 2022 (it was 5.32% in 2022, and imports of commodity group to India accounted for $29 billion).
Where does India import Antibiotics from?
Top trading partners (import of "Antibiotics") of India in 2023:
- China with a share of 86% (1.7 billion US$)
- Italy with a share of 2.47% (48 million US$)
- Austria with a share of 2.02% (39 million US$)
- Spain with a share of 1.64% (32 million US$)
- Mexico - 18.5 million US$
- Portugal - 14.8 million US$
- Korea - 10.2 million US$
- Slovenia - 10 million US$
- USA - 9.22 million US$
- Hungary - 7.97 million US$
Imports structure of 2941 - Antibiotics - to India in 2023 represented by the following main commodity groups:
- 47% (938 million US$): 294190 - Antibiotics & their derivatives (excl. of 2941); salts thereof
- 40% (795 million US$): 294110 - Penicillins & their derivatives with a penicillanic acid structure; salts thereof
- 8.14% (160 million US$): 294150 - Erythromycin & its derivatives; salts thereof
- 3.11% (61 million US$): 294130 - Tetracyclines & their derivatives; salts thereof
- 0.329% (6.47 million US$): 294120 - Streptomycins & their derivatives; salts thereof
- 0.114% (2.24 million US$): 294140 - Chloramphenicol & its derivatives; salts thereof
